NOVEOS Specific IgE (sIgE); Capture Reagent F004, Wheat (Triticum aestivum); Capture Reagent F023, Crab (Callinectes spp.); Capture Reagent F079, Gluten, Wheat; Capture Reagent F202, Cashew Nut (Anacardium occidentale); Capture Reagent F233, Gal d 1 Ovomucoid Egg
Hycor Biomedical · Decision date Jun 18, 2026
What did the FDA decide?
FDA records K260280 as a 510(k) premarket notification, with a decision dated Jun 18, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Immunology
- Decision date
- Jun 18, 2026
Regulatory record facts
- Identifier
- K260280
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Hycor Biomedical
- Product code
- DHB
- Decision code
- SESE
- Decision date
- Jun 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Test, Radioallergosorbent (Rast) Immunological.
- Applicant
- Hycor Biomedical
- Product code
- DHB
- FDA device class
- 2
FDA decision timeline
K260280 received
Application receipt date recorded by FDA.
K260280 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DHB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Siemens Healthcare Diagnostics Products, Ltd. | 510(k) clearance | Nov 2, 2026 | FDA | |
| Siemens Healthcare Diagnostics Products, Ltd. | 510(k) clearance | Sep 4, 2026 | FDA | |
| Hycor Biomedical | 510(k) clearance | Jul 24, 2026 | FDA | |
| Hycor Biomedical | 510(k) clearance | Jul 21, 2026 | FDA | |
| Hycor Biomedical | 510(k) clearance | May 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hycor Biomedical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Garden Grove, CA
Sources and methodology
- Original FDA record: K260280
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

